Flagship Pioneering demonstrated further acceleration in its strategic partnership with Pfizer Inc, announcing two research programs with Flagship-founded Quotient Therapeutics. Under the collaboration, the...
Relay Therapeutics, Inc., a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, announced a clinical trial...
Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for VELSIPITY (etrasimod) in the European Union to treat patients 16 years...
Pfizer Inc., announced the successful completion of its acquisition of Seagen Inc., a global biotechnology company that discovers, develops and commercializes transformative cancer medicines....
IDEAYA Biosciences, Inc, a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced further interim results from its Phase...
